Related content

Factors of Response to Pegylated Interferon/Ribavirin Combination Therapy and Mechanism of Viral Clearance

By  

Digestive Diseases, Vol. 31, Iss. 5-6, 2013-11 ,pp. : 421-425

Karger

Access to resources Recommend Favorite

Adequate timing of ribavirin reduction in patients with hemolysis during combination therapy of interferon and ribavirin for chronic hepatitis C

By Arase Yasuji   Ikeda Kenji   Suzuki Fumitaka   Suzuki Yoshiyuki   Saitoh Satoshi   Kobayashi Masahiro   Akuta Norio   Someya Takashi   Hosaka Tetsuya   Sezaki Hitomi   Kobayashi Mariko   Kumada Hiromitsu  

Journal of Gastroenterology, Vol. 39, Iss. 11, 2004-11 ,pp. : 1090-1094

Springer Publishing Company

Access to resources Recommend Favorite

Early Viral Response Predicts the Efficacy of Antiviral Triple Therapy with Simeprevir, Peg-Interferon and Ribavirin in Patients Infected with Hepatitis C Virus Genotype 1

By  

Digestive Diseases, Vol. 33, Iss. 6, 2015-0 ,pp. : 708-714

Karger

Access to resources Recommend Favorite

Prediction of Response to Pegylated Interferon/Ribavirin Combination Therapy for Chronic Hepatitis C Genotypes 2a and 2b and High Viral Load

By  

Digestive Diseases, Vol. 31, Iss. 5-6, 2013-11 ,pp. : 426-433

Karger

Access to resources Recommend Favorite

Early decline of hemoglobin correlates with progression of ribavirin-induced hemolytic anemia during interferon plus ribavirin combination therapy in patients with chronic hepatitis C

By Oze Tsugiko   Hiramatsu Naoki   Kurashige Nao   Tsuda Natsuko   Yakushijin Takayuki   Kanto Tatsuya   Takehara Tetsuo   Kasahara Akinori   Kato Michio   Yoshihara Harumasa   Katayama Kazuhiro   Kubota Shinji   Hijioka Taizo   Ishibashi Kazunobu   Oshita Masahide   Hagiwara Hideki   Haruna Yoshimichi   Mita Eiji   Tamura Shinji   Hayashi Norio  

Journal of Gastroenterology, Vol. 41, Iss. 9, 2006-09 ,pp. : 862-872

Springer Publishing Company

Access to resources Recommend Favorite